Literature DB >> 17374439

An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.

David S Aaronson1, Melissa Muller, Susana R Neves, Wen-Chen Chung, Gomathi Jayaram, Ravi Iyengar, Prahlad T Ram.   

Abstract

Dynamic modulation of information flow within signaling networks allows the cell to respond to micro-environmental changes. This property of the cell, while being essential to survival and eliciting appropriate responses, can also be detrimental to the organism by allowing cancerous cells to evade regulation and proliferate. We determined if changes in expression levels of transcriptional regulators and their interactions could alter routing within signaling networks in prostate cancer cells. Increasing the protein levels of the signal transducer and activator of transcription 3 (Stat3) led to Stat3-androgen receptor (AR) complex formation in response to epidermal growth factor (EGF) and interleukin-6 (IL-6) stimulation. Increasing the protein levels of Stat3 increased the EGF induced transcriptional activation of the androgen receptor. Androgen pre-treatment increased Stat3 protein levels in an IL-6 autocrine/paracrine dependent manner in the cells suggesting a feedback loop within cells. Increased Stat3-AR complex leads to a change in the routing of the epidermal growth factor signal allowing the androgen receptor to become activated in a Stat3 dependent manner. Understanding interactions and changes in signal flow within the cell is important to our understanding of signaling networks as well as our ability to identify cellular targets for novel therapies to inhibit cancer progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374439     DOI: 10.1016/j.mce.2007.02.006

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  22 in total

1.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

Review 2.  Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?

Authors:  Henry F Vischer; Marco Siderius; Rob Leurs; Martine J Smit
Journal:  Nat Rev Drug Discov       Date:  2014-01-21       Impact factor: 84.694

3.  Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer.

Authors:  Zhe Zhang; Long Chen; Hexiang Wang; Nihal Ahmad; Xiaoqi Liu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Pathogenesis of prostate cancer: lessons from basic research.

Authors:  Vamsidhar Velcheti; Satish Karnik; Stephen F Bardot; Om Prakash
Journal:  Ochsner J       Date:  2008

Review 5.  Prostate cancer: the need for biomarkers and new therapeutic targets.

Authors:  Juliana Felgueiras; Joana Vieira Silva; Margarida Fardilha
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

Review 6.  Androgen action and metabolism in prostate cancer.

Authors:  Sean M Green; Elahe A Mostaghel; Peter S Nelson
Journal:  Mol Cell Endocrinol       Date:  2012-03-20       Impact factor: 4.102

Review 7.  Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

8.  Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.

Authors:  Belen Elguero; Geraldine Gueron; Jimena Giudice; Martin A Toscani; Paola De Luca; Florencia Zalazar; Federico Coluccio-Leskow; Roberto Meiss; Nora Navone; Adriana De Siervi; Elba Vazquez
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

9.  Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.

Authors:  Aiyu Gong; Meilan He; Donkena Krishna Vanaja; Ping Yin; R Jeffrey Karnes; Charles Y F Young
Journal:  Mol Nutr Food Res       Date:  2009-07       Impact factor: 5.914

10.  Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.

Authors:  Rajeev Mishra; Subhash Haldar; Veronica Placencio; Anisha Madhav; Krizia Rohena-Rivera; Priyanka Agarwal; Frank Duong; Bryan Angara; Manisha Tripathi; Zhenqiu Liu; Roberta A Gottlieb; Shawn Wagner; Edwin M Posadas; Neil A Bhowmick
Journal:  J Clin Invest       Date:  2018-07-26       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.